Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.525 USD | -6.64% | +14.24% | +12.54% |
04:26pm | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
02:57pm | Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.61% | 3.02B | |
+34.54% | 472B | |
+6.86% | 138B | |
+32.61% | 98.36B | |
+6.94% | 93.44B | |
+59.69% | 59.13B | |
+18.12% | 47.5B | |
+30.27% | 39.41B | |
-0.19% | 35.99B | |
+15.06% | 29.22B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- GoodRx Holdings Appoints Scott Wagner Interim CEO